The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: Results of the multi-centre CHAMPS trial

British Journal of Haematology

Volumn 152, Issue 6, 2011, Pages 771-776

  Wang, Winfred C ^a   Brugnara, Carlo ^b   Snyder, Cathie ^c   Wynn, Lynn ^a   Rogers, Zora ^d   Kalinyak, Karen ^e   Brown, Clark ^f   Qureshi, Asif ^g   Bigelow, Carolyn ^h   Neumayr, Lynne ⁱ   Smith Whitley, Kim ^j   Chui, David H K ^g   Delahunty, Mardee ^k   Woolson, Rob ^c   Steinberg, Martin ^g   Telen, Marilyn ^k   Kesler, Karen ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c RHO INC   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

ⁱ CHILDREN S HOSPITAL OAKLAND   (United States)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Hb SC disease; Hydroxycarbamide; Hydroxyurea; Magnesium; Sickle cell

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA; LAMININ RECEPTOR; MAGNESIUM; PLACEBO; POTASSIUM; POTASSIUM CHLORIDE COTRANSPORTER; PYROGLUTAMATE MAGNESIUM; SODIUM;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CELL DENSITY; CHILD; CLINICAL ARTICLE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FATALITY; ERYTHROCYTE COUNT; ERYTHROCYTE VOLUME; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HEMOGLOBIN SC DISEASE; HUMAN; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIGRAINE; MULTICENTER STUDY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RETICULOCYTE COUNT; SCHOOL CHILD; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; ANTISICKLING AGENTS; BIOLOGICAL MARKERS; CELL ADHESION; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; FETAL HEMOGLOBIN; HEMOGLOBIN SC DISEASE; HUMANS; HYDROXYUREA; MAGNESIUM; MALE; MIDDLE AGED;

EID: 79951982532     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08523.x     Document Type: Article

References (13)

1. De Franceschi, L., Beuzard, Y., Jouault, H. & Brugnara, C. (1996) Modulation of erythrocyte potassium-chloride cotransport, potassium content and density by dietary magnesium intake in trangenic SAD mouse. Blood, 88, 2738-2744.
2. De Franceschi, L., Bachir, D., Galacteros, F., Tchernia, G., Cynober, T., Alper, S., Platt, O., Beuzard, Y. & Brugnara, C. (1997) Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. Journal of Clinical Investigation, 100, 1847-1852.
3. De Franceschi, L., Bachir, D., Galacteros, F., Tchernia, G., Cynober, T., Neuberg, D., Beuzard, Y. & Brugnara, C. (2000) Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. British Journal of Haematology, 108, 284-289.
4. Hankins, J., Wynn, L., Brugnara, C., Hillery, C., Li, C.-S. & Wang, W. (2007) Phase I study of magnesium pidolate in combination with hydroxyurea for children with sickle cell anemia. British Journal of Haematology, 140, 80-85.
5. Hillery, C.A., Du, M.C., Wang, W.C. & Scott, J.P. (2000) Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin. British Journal of Haematology, 109, 322-327.
6. Iyer, R., Baliga, R., Nagel, R.L., Brugnara, C., Kirchner, K., Hogan, S. & Steinberg, M.H. (2000) Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea. American Journal of Hematology, 64, 47-52.
7. Miller, M.K., Zimmerman, S.A., Schultz, W.H. & Ware, R.E. (2001) Hydroxyurea therapy for pediatric patients with haemoglobin SC disease. Journal of Pediatric Hematology Oncology, 23, 306-308.
8. Nagel, R.L., Fabry, M.E. & Steinberg, M.H. (2003) The paradox of hemoglobin SC disease. Blood Reviews, 17, 167-178.
9. Odièvre, M.-H., Bony, V., Benkerrou, M., Lapouméroulie, C., Alberti, C., Ducrocq, R., Jacqz-Aigrain, E., Elion, J. & Cartron, J.-P. (2008) Modulation of erythroid adhesion receptors expression by hydroxyurea in children with sickle cell disease. Haematologica, 93, 502-510.
10. Pocock, S.J. & Simon, R. (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31, 103-115.
11. Rivera, A., Ferreira, A., Bertoni, D., Romero, J.R. & Brugnara, C. (2005) Abnormal regulation of Mg2+ transport via Na/Mg exchange in sickle erythrocytes. Blood, 105, 382-386.
12. Steinberg, M.H., Nagel, R.L. & Brugnara, C. (1997) Cellular effects of hydroxyurea in Hb SC disease. British Journal of Haematology, 98, 838-844.
13. Zennadi, R., Hines, P.C., De Castro, L.M., Cartron, J.-P., Parise, L.V. & Telen, M.J. (2004) Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-αvβ3 interactions. Blood, 104, 3774-3781.